Amiodarone
The metabolism of Roxithromycin can be decreased when combined with Amiodarone.
Apalutamide
The serum concentration of Roxithromycin can be decreased when it is combined with Apalutamide.
Aprepitant
The serum concentration of Roxithromycin can be increased when it is combined with Aprepitant.
Atazanavir
The metabolism of Roxithromycin can be decreased when combined with Atazanavir.
Atomoxetine
The metabolism of Roxithromycin can be decreased when combined with Atomoxetine.
Atorvastatin
The risk or severity of adverse effects can be increased when Roxithromycin is combined with Atorvastatin.
BCG Vaccine
The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Roxithromycin.
Boceprevir
The metabolism of Roxithromycin can be decreased when combined with Boceprevir.
Bortezomib
The metabolism of Roxithromycin can be decreased when combined with Bortezomib.
Bosentan
The serum concentration of Roxithromycin can be decreased when it is combined with Bosentan.
Bosutinib
The serum concentration of Bosutinib can be increased when it is combined with Roxithromycin.
Bosutinib monohydrate
The serum concentration of Bosutinib can be increased when it is combined with Roxithromycin.
Bromocriptine
The risk or severity of adverse effects can be increased when Bromocriptine is combined with Roxithromycin.
Cabergoline
The risk or severity of adverse effects can be increased when Cabergoline is combined with Roxithromycin.
Carbamazepine
The metabolism of Roxithromycin can be increased when combined with Carbamazepine.
Ceritinib
The serum concentration of Roxithromycin can be increased when it is combined with Ceritinib.
Cerivastatin
The serum concentration of Cerivastatin can be increased when it is combined with Roxithromycin.
Cisapride
The serum concentration of Cisapride can be increased when it is combined with Roxithromycin.
Clarithromycin
The metabolism of Roxithromycin can be decreased when combined with Clarithromycin.
Clemastine
The metabolism of Roxithromycin can be decreased when combined with Clemastine.
Clotrimazole
The metabolism of Roxithromycin can be decreased when combined with Clotrimazole.
Cobicistat
The metabolism of Roxithromycin can be decreased when combined with Cobicistat.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Roxithromycin.
Crizotinib
The metabolism of Roxithromycin can be decreased when combined with Crizotinib.
Cyclosporine
The metabolism of Roxithromycin can be decreased when combined with Cyclosporine.
Dabrafenib
The serum concentration of Roxithromycin can be decreased when it is combined with Dabrafenib.
Darunavir
The metabolism of Roxithromycin can be decreased when combined with Darunavir.
Dasatinib
The serum concentration of Roxithromycin can be increased when it is combined with Dasatinib.
Dasatinib Anhydrous
The serum concentration of Roxithromycin can be increased when it is combined with Dasatinib.
Deferasirox
The serum concentration of Roxithromycin can be decreased when it is combined with Deferasirox.
Delavirdine
The metabolism of Roxithromycin can be decreased when combined with Delavirdine.
Deutetrabenazine
Roxithromycin may increase the QTc-prolonging activities of Deutetrabenazine.
Dihydroergotamine
The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Roxithromycin.
Diltiazem
The metabolism of Roxithromycin can be decreased when combined with Diltiazem.
Doxycycline
The metabolism of Roxithromycin can be decreased when combined with Doxycycline.
Doxycycline Anhydrous
The metabolism of Roxithromycin can be decreased when combined with Doxycycline.
Dronedarone
The metabolism of Roxithromycin can be decreased when combined with Dronedarone.
Enzalutamide
The serum concentration of Roxithromycin can be decreased when it is combined with Enzalutamide.
ergoloid mesylates, USP
The serum concentration of Ergoloid mesylate can be increased when it is combined with Roxithromycin.
Ergonovine
The risk or severity of adverse effects can be increased when Ergonovine is combined with Roxithromycin.
Ergotamine
The risk or severity of adverse effects can be increased when Ergotamine is combined with Roxithromycin.
Erythromycin
The metabolism of Roxithromycin can be decreased when combined with Erythromycin.
Fluconazole
The metabolism of Roxithromycin can be decreased when combined with Fluconazole.
Fluvastatin
The serum concentration of Fluvastatin can be increased when it is combined with Roxithromycin.
Fluvoxamine
The metabolism of Roxithromycin can be decreased when combined with Fluvoxamine.
Fosamprenavir
The metabolism of Roxithromycin can be decreased when combined with Fosamprenavir.
Fosaprepitant
The serum concentration of Roxithromycin can be increased when it is combined with Fosaprepitant.
Fosphenytoin
The metabolism of Roxithromycin can be increased when combined with Fosphenytoin.
Fusidate
The serum concentration of Roxithromycin can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Roxithromycin can be increased when it is combined with Fusidic Acid.
Hypoxis hemerocallidea root extract
The serum concentration of Roxithromycin can be decreased when it is combined with St. John's Wort.
Ibrutinib
The serum concentration of Ibrutinib can be increased when it is combined with Roxithromycin.
Idelalisib
The metabolism of Roxithromycin can be decreased when combined with Idelalisib.
Imatinib
The metabolism of Roxithromycin can be decreased when combined with Imatinib.
Indinavir
The metabolism of Roxithromycin can be decreased when combined with Indinavir.
INDINAVIR ANHYDROUS
The metabolism of Roxithromycin can be decreased when combined with Indinavir.
Isavuconazole
The serum concentration of Roxithromycin can be increased when it is combined with Isavuconazole.
Isavuconazonium
The metabolism of Roxithromycin can be decreased when combined with Isavuconazonium.
Isradipine
The metabolism of Roxithromycin can be decreased when combined with Isradipine.
Itraconazole
The metabolism of Roxithromycin can be decreased when combined with Itraconazole.
Ivacaftor
The serum concentration of Roxithromycin can be increased when it is combined with Ivacaftor.
Ketoconazole
The metabolism of Roxithromycin can be decreased when combined with Ketoconazole.
Lisuride
The risk or severity of adverse effects can be increased when Lisuride is combined with Roxithromycin.
Lopinavir
The metabolism of Roxithromycin can be decreased when combined with Lopinavir.
Lovastatin
The serum concentration of Lovastatin can be increased when it is combined with Roxithromycin.
Luliconazole
The serum concentration of Roxithromycin can be increased when it is combined with Luliconazole.
Lumacaftor
The metabolism of Roxithromycin can be increased when combined with Lumacaftor.
Macimorelin
Roxithromycin may increase the QTc-prolonging activities of Macimorelin.
Metergoline
The risk or severity of adverse effects can be increased when Metergoline is combined with Roxithromycin.
Methylergonovine
The risk or severity of adverse effects can be increased when Methylergometrine is combined with Roxithromycin.
Methysergide
The risk or severity of adverse effects can be increased when Methysergide is combined with Roxithromycin.
Mifepristone
The serum concentration of Roxithromycin can be increased when it is combined with Mifepristone.
Mitotane
The serum concentration of Roxithromycin can be decreased when it is combined with Mitotane.
Nefazodone
The metabolism of Roxithromycin can be decreased when combined with Nefazodone.
Nelfinavir
The metabolism of Roxithromycin can be decreased when combined with Nelfinavir.
Netupitant
The serum concentration of Roxithromycin can be increased when it is combined with Netupitant.
Nevirapine
The metabolism of Roxithromycin can be increased when combined with Nevirapine.
Nicergoline
The risk or severity of adverse effects can be increased when Nicergoline is combined with Roxithromycin.
Nilotinib
The metabolism of Roxithromycin can be decreased when combined with Nilotinib.
Olaparib
The metabolism of Roxithromycin can be decreased when combined with Olaparib.
Osimertinib
The serum concentration of Roxithromycin can be increased when it is combined with Osimertinib.
Palbociclib
The serum concentration of Roxithromycin can be increased when it is combined with Palbociclib.
Pentobarbital
The metabolism of Roxithromycin can be increased when combined with Pentobarbital.
Pergolide
The risk or severity of adverse effects can be increased when Pergolide is combined with Roxithromycin.
Phenobarbital
The metabolism of Roxithromycin can be increased when combined with Phenobarbital.
Phenytoin
The metabolism of Roxithromycin can be increased when combined with Phenytoin.
Picosulfuric Acid
The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Roxithromycin.
Pitavastatin
The serum concentration of Pitavastatin can be increased when it is combined with Roxithromycin.
Posaconazole
The metabolism of Roxithromycin can be decreased when combined with Posaconazole.
Pravastatin
The serum concentration of Pravastatin can be increased when it is combined with Roxithromycin.
Primidone
The metabolism of Roxithromycin can be increased when combined with Primidone.
Ranolazine
The metabolism of Roxithromycin can be decreased when combined with Ranolazine.
Ribociclib
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Roxithromycin.
Rifabutin
The metabolism of Roxithromycin can be increased when combined with Rifabutin.
Rifampin
The metabolism of Roxithromycin can be increased when combined with Rifampicin.
Rifapentine
The metabolism of Roxithromycin can be increased when combined with Rifapentine.
Rilpivirine
The serum concentration of Rilpivirine can be increased when it is combined with Roxithromycin.
Rosuvastatin
The serum concentration of Rosuvastatin can be increased when it is combined with Roxithromycin.
Rucaparib
The metabolism of Roxithromycin can be decreased when combined with Rucaparib.
Saquinavir
The metabolism of Roxithromycin can be decreased when combined with Saquinavir.
Saquinavir Mesylate
The metabolism of Roxithromycin can be decreased when combined with Saquinavir.
Sarilumab
The therapeutic efficacy of Roxithromycin can be decreased when used in combination with Sarilumab.
Sildenafil
The metabolism of Roxithromycin can be decreased when combined with Sildenafil.
Siltuximab
The serum concentration of Roxithromycin can be decreased when it is combined with Siltuximab.
Simeprevir
The serum concentration of Roxithromycin can be increased when it is combined with Simeprevir.
Simvastatin
The serum concentration of Simvastatin can be increased when it is combined with Roxithromycin.
ST. JOHN'S WORT EXTRACT
The serum concentration of Roxithromycin can be decreased when it is combined with St. John's Wort.
Sulfisoxazole
The metabolism of Roxithromycin can be decreased when combined with Sulfisoxazole.
Telaprevir
The metabolism of Roxithromycin can be decreased when combined with Telaprevir.
Telithromycin
The metabolism of Roxithromycin can be decreased when combined with Telithromycin.
Terfenadine
The serum concentration of Terfenadine can be increased when it is combined with Roxithromycin.
Ticlopidine
The metabolism of Roxithromycin can be decreased when combined with Ticlopidine.
Tocilizumab
The serum concentration of Roxithromycin can be decreased when it is combined with Tocilizumab.
Tolvaptan
The serum concentration of Tolvaptan can be increased when it is combined with Roxithromycin.
Vemurafenib
The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Roxithromycin.
Venlafaxine
The metabolism of Roxithromycin can be decreased when combined with Venlafaxine.
Verapamil
The metabolism of Roxithromycin can be decreased when combined with Verapamil.
Voriconazole
The metabolism of Roxithromycin can be decreased when combined with Voriconazole.
Ziprasidone
The metabolism of Roxithromycin can be decreased when combined with Ziprasidone.
MEDINDIA
Email



